Effects of hydrogen sulphide in an experimental model of renal ischaemia-reperfusion injury

British Journal of Surgery

Volumn 99, Issue 12, 2012, Pages 1665-1671

  Hunter, J P ^a   Hosgood, S A ^a   Patel, M ^a   Rose, R ^b   Read, K ^b   Nicholson, M L ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b HUNTINGDON LIFE SCIENCES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CREATININE; HYDROGEN SULFIDE; TUMOR NECROSIS FACTOR ALPHA; UREA;

ACUTE KIDNEY FAILURE; ANIMAL; ARTICLE; BLOOD; DISEASE MODEL; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY; LIGATION; NEUTROPHIL CHEMOTAXIS; PHYSIOLOGY; RANDOMIZATION; REPERFUSION INJURY; SWINE; VASCULARIZATION;

ACUTE KIDNEY INJURY; ANIMALS; BIOLOGICAL MARKERS; CONSTRICTION; CREATININE; DISEASE MODELS, ANIMAL; FEMALE; HYDROGEN SULFIDE; INFUSIONS, INTRAVENOUS; KIDNEY; NEUTROPHIL INFILTRATION; RANDOM ALLOCATION; REPERFUSION INJURY; SUS SCROFA; TUMOR NECROSIS FACTOR-ALPHA; UREA;

EID: 84868659904     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.8956     Document Type: Article

References (32)

1. Summers DM, Johnson RJ, Allen J, Fuggle SV, Collett D, Watson CJ, et al., Analysis of factors that affect outcome after transplantation of kidneys donated after cardiac death in the UK: a cohort study. Lancet 2010; 376: 1303-1311.
2. Siedlecki A, Irish W, Brennan DC,. Delayed graft function in the kidney transplant. Am J Transplant 2011; 11: 2279-2296.
3. Ojo AO, Wolfe RA, Held PJ, Port FK, Schmouder RL,. Delayed graft function: risk factors and implications for renal allograft survival. Transplantation 1997; 63: 968-974.
4. Smith RP, Gosselin RE,. Hydrogen sulfide poisoning. J Occup Med 1979; 21: 93-97.
5. Kang K, Zhao M, Jiang H, Tan G, Pan S, Sun X,. Role of hydrogen sulfide in hepatic ischemia-reperfusion-induced injury in rats. Liver Transpl 2009; 15: 1306-1314.
6. Fu Z, Liu X, Geng B, Fang L, Tang C,. Hydrogen sulfide protects rat lung from ischemia-reperfusion injury. Life Sci 2008; 82: 1196-1202.
7. Hosgood SA, Nicholson ML,. Hydrogen sulphide ameliorates ischaemia-reperfusion injury in an experimental model of non-heart-beating donor kidney transplantation. Br J Surg 2010; 97: 202-209.
8. Bliksoen M, Kaljusto ML, Vaage J, Stenslokken KO,. Effects of hydrogen sulphide on ischaemia-reperfusion injury and ischaemic preconditioning in the isolated, perfused rat heart. Eur J Cardiothorac Surg 2008; 34: 344-349.
9. Chen Y, Liu Z, Xie X,. Hydrogen sulphide attenuates renal and cardiac injury after total hepatic ischemia and reperfusion. J Surg Res 2010; 164: e305-e313.
10. Henderson PW, Jimenez N, Ruffino J, Sohn AM, Weinstein AL, Krijgh DD, et al., Therapeutic delivery of hydrogen sulfide for salvage of ischemic skeletal muscle after the onset of critical ischemia. J Vasc Surg 2011; 53: 785-791.
11. Henderson PW, Singh SP, Weinstein AL, Nagineni V, Rafii DC, Kadouch D, et al., Therapeutic metabolic inhibition: hydrogen sulfide significantly mitigates skeletal muscle ischemia reperfusion injury in vitro and in vivo. Plast Reconstr Surg 2010; 126: 1890-1898.
12. Li L, Rose P, Moore PK,. Hydrogen sulfide and cell signaling. Annu Rev Pharmacol Toxicol 2011; 51: 169-187.
13. Tripatara P, Patel NS, Collino M, Gallicchio M, Kieswich J, Castiglia S, et al., Generation of endogenous hydrogen sulfide by cystathionine gamma-lyase limits renal ischemia/reperfusion injury and dysfunction. Lab Invest 2008; 88: 1038-1048.
14. Sivarajah A, Collino M, Yasin M, Benetti E, Gallicchio M, Mazzon E, et al., Anti-apoptotic and anti-inflammatory effects of hydrogen sulfide in a rat model of regional myocardial I/R. Shock 2009; 31: 267-274.
15. Shi S, Li QS, Li H, Zhang L, Xu M, Cheng JL, et al., Anti-apoptotic action of hydrogen sulfide is associated with early JNK inhibition. Cell Biol Int 2009; 33: 1095-1101.
16. Elrod JW, Calvert JW, Morrison J, Doeller JE, Kraus DW, Tao L, et al., Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci U S A 2007; 104: 15 560-15 565.
17. Kimura H, Shibuya N, Kimura Y,. Hydrogen sulfide is a signaling molecule and a cytoprotectant. Antioxid Redox Signal 2012; 17: 45-57.
18. Simon F, Scheuerle A, Groger M, Stahl B, Wachter U, Vogt J, et al., Effects of intravenous sulfide during porcine aortic occlusion-induced kidney ischemia/reperfusion injury. Shock 2011; 35: 156-163.
19. Dongõ E, Hornyák I, Benko Z, Kiss L,. The cardioprotective potential of hydrogen sulfide in myocardial ischemia/reperfusion injury (review). Acta Physiol Hung 2011; 98: 369-381.
20. Yang B, Hosgood SA, Bagul A, Waller HL, Nicholson ML,. Erythropoietin regulates apoptosis, inflammation and tissue remodelling via caspase-3 and IL-1beta in isolated hemoperfused kidneys. Eur J Pharmacol 2011; 660: 420-430.
21. Szabo G, Veres G, Radovits T, Gero D, Modis K, Miesel-Groschel C, et al., Cardioprotective effects of hydrogen sulfide. Nitric Oxide 2011; 25: 201-210.
22. Ganster F, Burban M, de la Bourdonnaye M, Fizanne L, Douay O, Loufrani L, et al., Effects of hydrogen sulfide on hemodynamics, inflammatory response and oxidative stress during resuscitated hemorrhagic shock in rats. Crit Care 2010; 14: R165.
23. Liu Y, Kalogeris T, Wang M, Zuidema MY, Wang Q, Dai H, et al., Hydrogen sulfide preconditioning or neutrophil depletion attenuates ischemia-reperfusion- induced mitochondrial dysfunction in rat small intestine. Am J Physiol Gastrointest Liver Physiol 2012; 302: G44-G54.
24. Gao Y, Yao X, Zhang Y, Li W, Kang K, Sun L, et al., The protective role of hydrogen sulfide in myocardial ischemia-reperfusion-induced injury in diabetic rats. Int J Cardiol 2011; 152: 177-183.
25. Semenykhina OM, Baziliuk OV, Korkach I, Sahach VF,. [The effect of hydrogen sulfide on contractile activity of the vascular smooth muscles in rats.] Fiziol Zh 2011; 57: 3-11.
26. Nicholson CK, Calvert JW,. Hydrogen sulfide and ischemia-reperfusion injury. Pharmacol Res 2010; 62: 289-297.
27. 2S as a novel endogenous gaseous K(ATP) channel opener. EMBO J 2001; 20: 6008-6016.
28. 2S) protects against regional myocardial ischemia-reperfusion injury evidence for a role of K ATP channels. Basic Res Cardiol 2006; 101: 53-60.
29. Tang G, Wu L, Liang W, Wang R,. Direct stimulation of K(ATP) channels by exogenous and endogenous hydrogen sulfide in vascular smooth muscle cells. Mol Pharmacol 2005; 68: 1757-1764.
30. 2S contributes to the hepatic arterial buffer response and mediates vasorelaxation of the hepatic artery via activation of K(ATP) channels. Am J Physiol Gastrointest Liver Physiol 2008; 295: G1266-G1273.
31. Wallace JL, Ferraz JG, Muscara MN,. Hydrogen sulfide: an endogenous mediator of resolution of inflammation and injury. Antioxid Redox Signal 2012; 17: 58-67.
32. Sodha NR, Clements RT, Feng J, Liu Y, Bianchi C, Horvath EM, et al., Hydrogen sulfide therapy attenuates the inflammatory response in a porcine model of myocardial ischemia/reperfusion injury. J Thorac Cardiovasc Surg 2009; 138: 977-984.